Corrigendum re "A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)" [Eur Urol Focus 2022;8:173-81].
Wu Z, Chen Q, Djaladat H, Minervini A, Uzzo RG, Sundaram C, Rha KH, Gonzalgo ML, Mehrazin R, Mazzone E, Marcus J, Danno A, Porter J, Asghar A, Ghali F, Guruli G, Douglawi A, Cacciamani G, Ghoreifi A, Simone G, Margulis V, Ferro M, Tellini R, Mari A, Srivastava A, Steward J, Al-Qathani A, Al-Mujalhem A, Satish Bhattu A, Mottrie A, Abdollah F, Eun DD, Derweesh I, Veccia A, Autorino R, Wang L.
Wu Z, et al. Among authors: steward j.
Eur Urol Focus. 2024 May;10(3):502. doi: 10.1016/j.euf.2022.12.010. Epub 2023 Jan 2.
Eur Urol Focus. 2024.
PMID: 36588010
No abstract available.